Nuwellis, Inc.
NUWE • NASDAQ
Nuwellis, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO John L. Erb, with a market cap of $2.4M.
CEOJohn L. Erb
Next Earnings
Upcoming earnings announcement for Nuwellis, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.01
Revenue Estimate
$2.1M
Earnings History
Past 12 earnings reports for Nuwellis, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$1.50Est: -$1.56 | +3.8% | $2.4MEst: $2.3M | +4.9% |  10-K |
| Nov 12, 2025 | Q3 2025 | $0.56 | — | $2.2MEst: $2.8M | -21.5% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$60.99Est: -$0.45 | -13453.3% | $1.7MEst: $2.2M | -21.6% | 10-Q |
| May 13, 2025 | Q1 2025 | —Est: -$0.45 | — | —Est: $2.5M | — | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.71Est: -$0.43 | -65.1% | $2.3MEst: $2.5M | -7.1% | 10-K |
| Nov 11, 2024 | Q3 2024 | -$1.13Est: -$1.28 | +11.7% | $2.4MEst: $2.4M | +0.3% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$4.68Est: -$8.24 | +43.2% | $2.2MEst: $2.0M | +9.7% | 10-Q |
| May 7, 2024 | Q1 2024 | -$21.00Est: -$32.55 | +35.5% | $1.9MEst: $2.1M | -12.4% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$78.40Est: -$48.65 | -61.2% | $2.6MEst: $2.6M | +0.0% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$63.35Est: -$108.85 | +41.8% | $2.4MEst: $2.3M | +5.8% | — |
| Aug 8, 2023 | Q2 2023 | -$127.75Est: -$140.70 | +9.2% | $2.1MEst: $2.2M | -5.3% | 10-Q |
| May 9, 2023 | Q1 2023 | -$201.60Est: -$132.65 | -52.0% | $1.8MEst: $2.3M | -22.0% | — |